-
Information-Publications
-
Camouflaged Nanozyme with Oxidation-Promoting Activities Triggering Ferroptosis for RadioimmunotherapyDetails -
Asialoglycoprotein receptor 1 promotes SARS-CoV-2 infection of human normal hepatocytesDetails -
Donor-Cell Senescence Redirects PINK1-Marked Mitochondrial Cargo From Mitophagy to Microvesicle Transfer Through SUMO3-Stabilized HSPA9Details
-
"Heyuan Liji" is a joint venture between Heyuan Biotechnology (stock code: 688238) and Liji Biotechnology, specializing in the "Liji Biotechnology" and "Life-ilab" reagent brands
Back
